Role of immunotherapy in lung cancer: Preliminary results of new vaccines and immune checkpoint inhibitors

E-ISSN： 1743-7563|11|S1|2-8

ISSN： 1743-7555

Source： ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, Vol.11, Iss.S1, 2015-04, pp. : 2-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immune checkpoint inhibitors: new strategies to checkmate cancer

CLINICAL & EXPERIMENTAL IMMUNOLOGY, Vol. 191, Iss. 2, 2018-02 ,pp. : 133-148

John Wiley & Sons Inc

Access to resources Recommend Favorite

Immune checkpoint inhibitors in advanced non–small cell lung cancer

CANCER, Vol. 124, Iss. 2, 2018-01 ,pp. : 248-261

John Wiley & Sons Inc

Access to resources Recommend Favorite

Immune Checkpoint Inhibitors: New Insights and Current Place in Cancer Therapy

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 35, Iss. 10, 2015-10 ,pp. : 963-976

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical Trials Investigating Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer

Reviews on Recent Clinical Trials, Vol. 11, Iss. 4, 2016-10 ,pp. : 297-305

Bentham Science Publishers

Access to resources Recommend Favorite

New Advances in Lung Cancer Chemotherapy: Topotecan and the Role of Topoisomerase I Inhibitors

Oncology, Vol. 61, Iss. 1, 2001-09 ,pp. : 14-24

Karger

Access to resources Recommend Favorite